Price
$44.60-56.57%1Y
1M-23.05%1Y-56.57%
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Average5/10
Value56
Quality79
Momentum3
Growth57
P/E (TTM)-
Market Cap$67.32B
1Y Return-56.57%
5Y Return+3.93%
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $3.28B (-34.10%)
●Interventional Oncology And Embolization grew +19.72% YoY●Cardiac Rhythm Management -2.51% YoY
SegmentLatestQoQYoY
- Electrophysiology EP$603.0M-0.66%+18.00%
- Interventional Cardiology Therapies$552.0M+115.63%+18.20%
- Global Urologyand Pelvic Health Reporting Unit$465.0M-9.00%-0.85%
- Watchman$462.0M-1.70%+18.46%
- Global Endoscopy Endo Reporting Unit$446.0M-3.46%+6.19%
- Cardiac Rhythm Management$349.0M-1.41%-2.51%
- Global Neuromodulation Nm Reporting Unit$236.0M+2.61%+15.69%
- Interventional Oncology And Embolization$170.0M-+19.72%
- Global Cardiology Reporting Unit---
- Global Peripheral Interventions Pi Reporting Unit---
- Specialty Pharmaceuticals---